Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-207-2 | CAS number: 2156592-65-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1995
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study has been conducted to OECD guidelines and to GLP, however, has not been fully reported. In addition, as this study is used in the context of a read across, Klimisch 2 is assigned.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- arochlor induced rat liver S9 extract
- Test concentrations with justification for top dose:
- 10, 20,40,80,120,160 ug/ml
- Vehicle / solvent:
- tetrahydrofuran for test material
acetone for positive control - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 16 and 40 hours
SPINDLE INHIBITOR (cytogenetic assays): Colcemid
STAIN (for cytogenetic assays): Giemsa stain
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: 200 metaphase cells (100 per culture) each containing 19-23 chromosomes
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other:
- Evaluation criteria:
- cells with aberrant chromosomes.
- Statistics:
- Fisher exact test.
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Precipitate and/or cloudines were present with and without metabolic activation at concentrations of 39 µg/ml and greater.
RANGE-FINDING/SCREENING STUDIES: There was an 81% reduction in cell survival at 160 µg/ml, without metabolic activation, compared with control. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
The test material was not genotoxic under the conditions of this study. - Executive summary:
In a mammalian cell cytogenetics assay [chromosome aberration], CHO cell cultures were exposed to a petroleum derived calcium salt derivative at concentrations of 0, 10, 20, 40, 80, 120 and 160 µg/ml with and without S9 metabolic activation.
Positive controls induced the appropriate response. There was no evidence of chromosome aberrations induced over background with the test substance.
This study is classified as acceptable. This study satisfies the requirement for Test Guideline OECD 473 for in vitro cytogenetic mutagenicity data.
Reference
In the initial 16h harvest there were statistically significant increases with dose in the % of aberrant cells for both activated and non activated tests. These trends were not reproducible in the repeat 16h harvest and were therefore not considered biologically significant.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In a supporting study, a reverse gene mutation assay in bacteria (OECD 471), the strains TA98, TA100, TA1535 and TA 1537 of S. typhimurium and E. coli WP2uvrA were exposed to a calcium sulfonate read across substance, (analogue of CAS 70024-69-0), at concentrations of 0.1, 0.33, 1.0, 3.33 and 10 mg/plate in the presence and absence of mammalian metabolic activation (Myers et al., 1989). A Dose Range-finding Study was conducted using tester strains TA98 and TA100, and dose levels of test material ranging from 0.003 to 10 mg/plate were used. No cytotoxicity was observed in the dose range-finding study with tester strains TA100 and WP2uvrA with or without metabolic activation as evidenced by normal background lawn and no reduction in the number of revertants/plate. The S9 optimization study was performed using TA98 and TA100 with the highest non-cytotoxic dose of test article, (10 mg/plate) and concentrations of S9 mix of 25-400 μL. In the absence of any effect 25 μL S9 mix/plate was used in the mutagenicity study. In the main study there were two treatment sets for each tester strain, with (+S9) and without (-S9) metabolic activation. Each of the tester strains was dosed with five concentrations of test substance, vehicle controls, and a positive control. Three plates/dose group/strain/treatment set were evaluated. The results of the initial assay were confirmed in a second independent experiment. 100 μL of test material, positive control or vehicle control were added to each plate along with 100 μL of tester strain, S9 mix (if needed) and 2.0 mL of top agar. This was overlaid onto the surface of 25 mL minimal bottom agar in a petri dish. Plates were incubated for 48 hours at 37 °C. The condition of the bacterial background lawn was evaluated for cytotoxicity and test article precipitate. The test material formed a stable emulsion with the vehicle and the dilutions were well dispersed in the top agar. However ,after incubation test material was visible at all dose levels in the top layer. The test material was not cytotoxic to any tester strain. In the repeat study statistically significant increases in revertant colonies were observed in TA1535 without metabolic activation and in WP2uvrA with metabolic activation. However, since these findings were not found during the first experiment they were not considered biologically significant. The positive control for each respective test strain exhibited at least a 3-fold increase (with or without S9) over the mean value of the vehicle control for a given strain, confirming the expected positive control response. Dosing solution analysis confirmed that high dose concentration was acceptable. Therefore, the test substance was considered to be non-mutagenic without and with S9 mix in the plate incorporation as well as in the pre-incubation modification of the Salmonella/microsome test.
In a supporting study, a reverse gene mutation assay in bacteria (OECD 471), the test material (CAS 68783-96-0) was applied (doses of 250, 500, 1000, 2500 and 5000 μg/plate in the initial assay, and 1000, 2000, 3000, 4000 and 5000 in the repeat assay) in agar to the S. typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and TA 1538 (Sanitised, L., 1995). As metabolic activation system, S9 aroclor induced rat liver was used. Tetrahydrofuran was the vehicle for the test material, and DMSO was the vehicle for the positive controls (9-aminoacridine, 2-nitrofluorene and 2-aminoanthracene and N-methyl-N-Nitro-N-Nitrosoguanidine). Prior to study initiation the solubility of the test substance in the vehicle (tetrahydrofuran, 2 vehicle controls for each strain) was confirmed. In addition, one non-treated control and a positive control were tested for each strain. In the main study there were two treatment sets for each tester strain, with and without metabolic activation.
Three plates/dose group/strain/treatment set were evaluated. The results of the initial assay were verified by repeating the assay at dose levels of 1000, 2000, 3000, 4000 and 5000 μg/plate. After 2 days of incubation all plates in the initial and repeat assays were evaluated for gross-toxic effects and total revertant colony numbers. The test substance did not induce significant increases in revertant colonies (equal to or greater than three times the THF control) in any of the tester strains, at any dose level, with or without metabolic activation in the initial or repeat assays.
In a key mammalian cell gene mutation assay (OECD 476), mouse lymphoma L5178Y cells were exposed to a calcium sulfonate read across substance (CAS 68783-96-0), at concentrations of 0, 500, 1000, 1500, 2000, 4000 and 5000 μg/mL with and without S9 metabolic activation (Sanitised, D., 1984). As vehicle DMSO was used, as positive controls 7, 12-dimethylbenzanthracene and ethylmethanesulfonate were used. Prior to study initiation the solubility of the test substance and of the positive control materials in the vehicle (DMSO) was confirmed. A pre-test dose range finding study was conducted at concentrations up to 10,000 μg/mL with and without metabolic activation. In the main study there were two treatment sets for each concentration of test substance, with (+S9) and without (-S9) metabolic activation. DMBA (positive control) was tested with activation and EMS (positive control) was tested without activation. The test material was added to cells with and without activation and incubated for four hours. Cells were then washed and placed in suspension cultures for two days with a cell population adjustment at 24 hours. The cells were then plated in a restrictive media containing trifluorothymidine (TFT) which allows TK-/-cells to grow. Cells were also plated in a non-restrictive media that indicated cell viability. Plates were incubated at 37°C in a humidified 5 % CO2 atmosphere for 10-12 days. Following incubation all plates were scored for total number of colonies/plate. The frequency of mutation by dose was determined by comparing the average number of colonies in the mutagenicity plates to the average number of colonies in the corresponding viability plates. None of the cultures treated with test material with or without activation exhibited mutant frequencies significantly different from the average mutant frequency of the negative (solvent) controls at a per cent total growth of 10% or greater. Positive and vehicle control group responses were appropriate and met the criteria outlined above. So the test substance was not mutagenic in this assay with or without metabolic activation.
In a key mammalian cell cytogenetics assay [chromosome aberration] (OECD 473), Chinese hamster ovary (CHO, clone tested WBL) cell cultures were exposed to the read across substance calcium sulfonate substance, (CAS 68783-96-0), at concentrations of 0, 10, 20, 40, 80, 120 and 160 μg/mL with and without S9 metabolic activation according to OECD 473. As vehicle Tetrahydrofuran (THF, for the test material) and acetone (for the positive controls) was used. Positive controls induced the appropriate response. There was no evidence of chromosome aberrations induced over background with the test substance. In the initial 16-hours harvest there were statistically significant increases with dose in the % of aberrant cells for both activated and non-activated tests. These trends were not reproducible in the repeat 16-hours harvest and were therefore not considered biologically significant.
Justification for selection of genetic toxicity endpoint
In a key mammalian cell cytogenetics assay [chromosome aberration], Chinese hamster ovary (CHO, clone tested WBL) cell cultures were exposed to the read across substance calcium sulfonate substance, (CAS 68783-96-0), at concentrations of 0, 10, 20, 40, 80, 120 and 160 μg/mL with and without S9 metabolic activation according to OECD 473. As vehicle Tetrahydrofuran (THF, for the test material) and acetone (for the positive controls) was used. Positive controls induced the appropriate response. There was no evidence of chromosome aberrations induced over background with the test substance. In the initial 16h harvest there were statistically significant increases with dose in the % of aberrant cells for both activated and non activated tests. These trends were not reproducible in the repeat 16h harvest and were therefore not considered biologically significant.
Justification for classification or non-classification
Read across substances were negative for mutagenicity in two in vitro bacterial reverse mutation assay conducted according to OECD 471, an in vitro chromosome aberration assay conducted according to OECD 473, and an in vitro L5178Y TK +/- Mouse Lymphoma Forward Mutation Assay conducted according to OECD 476. Therefore, based on the weight of evidence from the available data, benzene, mono-C10-13-alkyl derivatives, distillation residues, sulfonated, sodium salt does not warrant classification for mutagenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.